Patent · US Active

Prolinamide derivatives as NK3 antagonists

US7528136B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bo Han · Shanghai, CN
Henner Knust · Rheinfelden (Baden), DE
Matthias Nettekoven · Weil am Rhein, DE
Hasane Ratni · Habsheim, FR
Xihan Wu · Shanghai, CN

Key dates

Filing date	May 30, 2008
Grant date	May 5, 2009
Priority date	—
Expiry date	May 30, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula Iwherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.